Trial Profile
A trial to evaluate the angiogenesis-related factors of the vascular endothelial growth factor (VEGF) family in the aqueous humour of patients with neovascular glaucoma (NVG)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Jun 2016
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary)
- Indications Neovascular glaucoma
- Focus Pharmacodynamics
- 24 Jun 2016 New trial record